An update on actively targeted liposomes in advanced drug delivery to glioma

An update on actively targeted liposomes in advanced drug delivery to glioma


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سولماز مجردجبلی , مسعود فرشباف آقاجانی , سالار همتی , پروین ذاکری میلانی , هادی ولیزاده

کلمات کلیدی: Glioma; Brain cancer; Liposome; Active targeting; Blood-brain barrier; Drug delivery

نشریه: 15315 , June 2021 , 602 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله هادی ولیزاده
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده داروسازی
کد مقاله 75799
عنوان فارسی مقاله An update on actively targeted liposomes in advanced drug delivery to glioma
عنوان لاتین مقاله An update on actively targeted liposomes in advanced drug delivery to glioma
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

High-grade glioma is one of the most aggressive types of cancer with a low survival rate ranging from 12 to 15 months after the first diagnosis. Though being the most common strategy for glioma therapy, conventional chemotherapy suffers providing the therapeutic dosage of common therapeutics mostly because of limited permeability of blood-brain barrier (BBB), and blood-brain tumor barrier (BBTB) to anticancer agents. Among various nanoformulations, liposomes are considered as the most popular carriers aimed for glioma therapy. However, non-targeted liposomes which passively accumulate in most of the cancer tissues mainly through the enhanced permeation and retention effect (EPR), may not be applicable for glioma therapy due to BBB tight junctions. In the recent decade, the surface modification of liposomes with different active targeting ligands has shown promising results by getting different chemotherapeutics across the BBB and BBTB and leading them into the glioma cells. The present review discusses the major barriers for drug delivery systems to glioma, elaborates the existing mechanisms for liposomes to traverse across the BBB, and explores the main strategies for incorporation of targeting ligands onto the liposomes. It subsequently investigates the most recent and relevant studies of actively targeted liposomes modified with antibodies, aptamers, monosaccharides, polysaccharides, proteins, and peptides applied for effective glioma therapy, and highlights the common challenges facing this area. Finally, the actively targeted liposomes undergoing preclinical and clinical studies for delivery of different anticancer agents to glioma cells will be reviewed.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سولماز مجردجبلیاول
مسعود فرشباف آقاجانیدوم
سالار همتیسوم
پروین ذاکری میلانیششم
هادی ولیزادههشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Review1.pdf1400/05/1612725626دانلود